Ingredion has announced the appointment of Diego Reynoso as the company's new Chief Financial Officer.

Ingredion Incorporated provided a summary of its Q2 2026 earnings call, outlining its financial performance and key business developments.

Several companies, including Workiva, Travere Therapeutics, and Duke Energy, have released their Q2 2026 earnings previews. These previews offer investors an early look at the financial performance of various businesses across different sectors.

Jim Cramer provided his investment insights on a range of companies, including Ford's battery business, banks like JPMorgan, Stryker, Vistra, Clover Health, Fair Isaac, Archer-Daniels-Midland, Tyson Foods, and Ingredion's potential after the Tate & Lyle deal.

Ingredion has reached an agreement to purchase Tate & Lyle in a deal valued at $3.6 billion, expanding its market presence.

Agilent Technologies announced a quarterly dividend of $0.255 per share, while Ingredion Incorporated declared a quarterly dividend of $0.82 per share. Both companies made their respective dividend declarations.

Ingredion has made available the transcript of its first-quarter 2026 earnings call, providing detailed insights into its financial performance and discussions.

Oppenheimer has slightly trimmed its price target for Ingredion (INGR) stock in anticipation of its first-quarter earnings report, though it still projects healthy results.

Ingredion has declared a dividend of $0.82 per share, to be distributed to its investors.

Ingredion has made available the transcript from its second-quarter 2026 earnings call, detailing its financial results and strategic discussions.

Ingredion projects its 2026 adjusted EPS to be between $10.30 and $10.90, while continuing to advance its deal with Tate & Lyle, aiming for $130 million in run-rate synergies by 2030.

Ingredion (INGR) has successfully completed the sale of its stake in Rafhan Maize for $165 million, finalizing the divestiture.

A weekly summary of significant business deals highlights transactions involving companies such as GSK, Incyte, Ingredion, and OpenAI, among others.

Ingredion is reportedly close to finalizing a $3.6 billion deal to acquire Tate & Lyle, marking another significant loss for the London market.

A summary of Ingredion Incorporated's first quarter 2026 earnings call has been released.

Analysts have offered their perspectives on several key consumer goods companies, including Ingredion (INGR), Coca-Cola Europacific Partners (CCEP), and The Hershey Company (HSY).

Knife River, Enlight Renewable Energy, Revvity, and Ingredion all reported strong Q2 results, beating both top-line and bottom-line estimates. These companies subsequently raised or updated their financial outlooks for fiscal year 2026.

An analysis explores whether Ingredion Incorporated (INGR) presents a favorable investment opportunity in the current market.

Tate & Lyle, a company reportedly targeted for takeover by Ingredion, has announced a fall in its profits.

Ingredion has made a $3.7 billion offer to acquire its ingredients rival, Tate & Lyle, in a significant move within the food ingredients industry.

Ingredion has announced the appointment of Jason Payant as its interim Chief Financial Officer, effective April 1.

Analysts have provided their perspectives and updated price targets for several food and beverage companies, including Ingredion, Bunge Global, Archer-Daniels-Midland, The Hershey Company, The J.M. Smucker Company, Keurig Dr. Pepper, Monster Beverage, and Mondelez International.